Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

January 21, 2025) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Inari Medical, Inc. ("Inari Medical") (NASDAQ: NARI) for ...

Monteverde & Associates PC (the 'M&A Class Action Firm'), has recovered millions of dollars for shareholders and is ...

Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...

Portage, Michigan, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE ... of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: NARI) for $80.00 per share in cash.

We recently compiled a list of the 10 Hottest Mid-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

Quanterix Corporation (NASDAQ: QTRX)'s merger with Akoya Biosciences, Inc. Upon completion of the proposed transaction, Quanterix shareholders will own approximately 70% of the combined company. If ...

UBS initiated coverage on Penumbra (NYSE:PEN), a medical technology company, with a Buy rating and a price target of $305.00.

Inari Medical is what I discussed before in an article talking about mid-cap stocks. Why is it surging so much this year? In short, Stryker announced it's buying Inari Medical for $4.9 billion at $80 ...